Possible increased risk for Alzheimer's disease associated with neprilysin gene

Journal of Neural Transmission

Volumn 110, Issue 6, 2003, Pages 651-657

  Clarimon J ^a   Munoz F J ^a   Boada, M ^a   Tarraga L ^a   Sunyer, J ^a   Bertranpetit, J ^a   Comas, D ^a  

^a UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

Alzheimer's disease; Apolipoprotein E; Case control study; Genetic polymorphism; Neprilysin

Indexed keywords

APOLIPOPROTEIN E; MEMBRANE METALLOENDOPEPTIDASE;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FUNCTION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR; SEX RATIO; SPAIN;

3' UNTRANSLATED REGIONS; AGE FACTORS; AGED; ALLELES; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; BRAIN; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HUMANS; MALE; NEPRILYSIN; POLYMORPHISM, GENETIC;

EID: 0038521161     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00702-002-0807-3     Document Type: Article

References (24)

1. Adroer R, Santacruz P, Blesa R, Lopez-Pousa S, Ascaso C, Oliva R (1995) Apolipo-protein E4 allele frequency in Spanish Alzheimer and control cases. Neurosci Lett 189: 182-186
2. Bullido MJ, Artiga MJ, Recuero M, Sastre I, Garcia MA, Aldudo J, Lendon C, Han SW, Morris JC, Frank A, Vazquez J, Goate A, Valdivieso F (1998) A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. Nat Genet 18: 69-71
3. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923
4. Clarimón J, Bertranpetit J, Calafell F, Boada M, Tàrraga L, Comas D (2002) Joint analysis of candidate genes related to Alzheimer's disease in a Spanish population. Psychiat Genet (in press)
5. Czech C, Monning V, Tienari PJ, Hartmann T, Masters C, Beyreuther K, Forstl H (1993) Apolipoprotein E-epsilon 4 allele and Alzheimer's disease. Lancet 342: 1309
6. D'Adamio L, Shipp MA, Masteller EL, Reinherz EL (1989) Organization of the gene encoding common acute lymphoblastic leukemia antigen (neutral endopeptidase 24.11): multiple miniexons and separate 5′ untranslated regions. Proc Natl Acad Sci USA 86: 7103-7107
7. Fukami S, Watanabe K, Iwata N, Haraoka J, Lu B, Gerard NP, Gerard C, Fraser P, Westaway D, St George-Hyslop P, Saido TC (2002) Abeta-degrading endopeptidase, neprilysin, in mouse brain: synaptic and axonal localization inversely correlating with Abeta pathology. Neurosci Res 43: 39-56
8. Hixson JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha I. J Lipid Res 31: 545-548
9. Iwata N, Tsubuki S Takaki Y, Shirotani K, Lu B, Gerard NP, Gerard C, Hama E, Lee HJ, Saido TC (2001) Metabolic regulation of brain Aβ by neprilysin. Science 292: 1550-1552
10. Iwata N, Takaki Y, Fukami S, Tsubuki S, Saido TC (2002) Region-specific reduction of Abeta-degrading endopeptidase, neprilysin, in mouse hippocampus upon aging. J Neurosci Res 70: 493-500
11. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Sevices Task Force on Alzheimer's disease. Neurology 34: 939-944
12. Mohajeri MH, Wollmer MA, Nitsch RM (2002) Abeta 42-induced increase in neprilysin is associated with prevention of amyloid plaque formation in vivo. J Biol Chem 277: 35460-35465
13. Muñoz FJ, Inestrosa NC (1999) Neurotoxicity of acetylcholinesterase amyloid beta-peptide aggregates is dependent on the type of Abeta peptide and the Ache concentration present in the complexes. FEBS Lett 450: 205-209
14. Oda M, Morino H, Maruyama H, Terasawa H, Izumi Y, Torii T, Sasaki K, Nakamura S, Kawakami H (2002) Dinucleotide repeat polymorphisms in the neprilysin gene are not associated with sporadic Alzheimer's disease. Neurosci Lett 320: 105-107
15. Poduslo SE, Yin X, Hargis J, Brumback RA, Mastrianni JA, Schwankhaus JA (1999) A familial case of Alzheimer's disease without tau pathology may be linked with chromosome 3 markers. Hum Genet 105: 32-37
16. Reilly CE (2001) Neprilysin content is reduced in Alzheimer brain areas. J Neurol 248: 159-160
17. Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, Hulette C, Crain B, Goldgaber D, Roses AD (1993) Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43: 1467-1472
18. Selkoe DJ (2000) The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol 8: 447-453
19. Shirotani K, Tsubuki S, Iwata N, Takaki Y, Harigaya W, Maruyama K, Kiryu-Seo S, Kiyama H, Iwata H, Tomita T, Iwatsubo T, Saido TC (2001) Neprilysin degrades both amyloid β peptides 1-40 and 1-42 most rapidly and efficiently among thiorphan - and phosphoramidon - sesitive endopeptidases. J Biol Chem 276: 21895-21901
20. Sodeyama N, Mizusawa H, Yamada M, Itoh Y, Otomo E, Matsushita M (2001) Lack of association of neprilysin polymorphism with Alzheimer's disease and Alzheimer's disease-type neuropathological changes. J Neurol Neurosurg Psychiatry 71: 817-818
21. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90: 1977-1981
22. Tanzi RE, Kovacs DM, Kim TW, Moir RD, Guenette SY, Wasco W (1996) The gene defects responsible for familial Alzheimer's disease. Neurobiol Dis 3: 159-168
23. Weber JL, Wong C (1993) Mutation of human short tandem repeats. Hum Mol Genet 44: 1123-1128
24. Yasojima K, Akiyama H, McGeer EG, McGeer PL (2001) Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of beta-amyloid peptide. Neurosci Lett 297: 97-100